AGIO up +9.20% percent Today $AGIO High is at 93.0
Post# of 83
Posted On: 11/19/2014 10:31:30 AM
AGIO up +9.20% percent Today $AGIO High is at 93.00 and the Low 83.68 with current volume of 1,516,641.
Recent News posted below.
Agios Pharmaceuticals Inc AGIO other info.
http://investorshangout.com/Agios-Pharmaceuti...GIO-90049/
AGIO Agios Pharmaceuticals Inc Recent Headline News
Stock Futures Take A Data Dive; Tesla Falls On Outlook Change
at Investor's Business Daily - 1 hr 19 mins ago
Stock futures fell out of flat trade to moderate losses ahead of Wednesday's open after a mixed read on October homebuilding activity. Dow futures slumped 18.8 points below fair market value. Nasdaq 100 futures traded down 6.3 points. S&P 500 futures...
SPLS: 13.98 (+1.22), LEJU: 12.45 (-1.71), TSLA: 248.10 (-9.60), FCAU: 12.18 (-0.63), LITB: 7.75 (+0.11), TTM: 46.46 (-0.70), DL: 17.75 (+2.78), VA: 36.84 (-0.21), TGT: 71.07 (+3.56), GM: 32.10 (-0.17), AGIO: 91.55 (+7.74), LOW: 61.76 (+3.23), HMC: 31.03 (-0.62), EJ: 8.66 (-0.87), PETM: 76.40 (+2.78)
Agios leukemia drug candidate shows clinical activity in Phase 1 trial
Seeking Alpha - at Seeking Alpha - 1 hr 29 mins ago
AGIO: 91.55 (+7.74)
Agios Cancer 'Metabolism' Drug Clears Bone Marrow of Leukemic Cells
at The Street - Tue Nov 18, 5:02PM CST
The experimental drug from Agios, designed to attack the "metabolism" of cancer cells, has demonstrated early but strong clinical responses in a study involving patients with advanced leukemia.
AGIO: 91.55 (+7.74), CELG: 106.02 (-0.76)
Agios Pharmaceuticals Announces Early Phase 1 Data Showing Clinical Activity of AG-120 as a Single Agent in Advanced Acute Myeloid Leukemia (AML)
GlobeNewswire - Tue Nov 18, 5:01PM CST
-Significant Clinical Responses and Reduction of 2HG Biomarker Provide Early Validation of Mutant IDH1 as a Therapeutic Target in AML -
AGIO: 91.55 (+7.74)
Jim Cramer Says to Buy Six Flags, Avoid SeaWorld Entertainment
at The Street - Wed Nov 12, 1:20PM CST
TheStreet's Jim Cramer says investors shouldn't be tricked by SeaWorld's attractive dividend yield. Instead, stick with Six Flags Entertainment.
SEAS: 17.20 (+0.14), SIX: 40.53 (-0.27), AGIO: 91.55 (+7.74)
Nasdaq stocks posting largest percentage increases
AP - Tue Nov 11, 5:02PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
ICUI: 84.37 (-1.19), OREX: 5.54 (-0.08), PCMI: 8.86 (+0.07), CYAN: 7.69 (-0.15), ACHN: 13.10 (-0.21), TGTX: 14.49 (-0.28), AGIO: 91.70 (+7.89), LIOX: 5.05 (-0.09), SAJA: 5.97 (-0.14), PLNR: 7.23 (-0.16)
Biotech Weekly: When Mid Caps Are Priced Nearly For Perfection
Daniel Ward - at Seeking Alpha - Mon Nov 10, 9:28AM CST
XBI: 170.72 (-0.66), SLXP: 104.96 (-0.43), ICPT: 157.87 (-4.63), IBB: 293.56 (-1.69), AGIO: 91.70 (+7.89)
Agios Pharmaceuticals' (AGIO) CEO David Schenkein on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Sat Nov 08, 6:31AM CST
AGIO: 91.70 (+7.89)
Premarket Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Nov 07, 8:14AM CST
BEBE: 2.63 (+0.06), ANET: 76.88 (+0.08), TKMR: 16.11 (-0.26), ORBC: 6.21 (-0.13), MDRX: 12.05 (-0.15), RMTI: 9.99 (-0.29), CTIC: 2.22 (-0.06), SHLD: 35.65 (-0.26), UBNT: 29.30 (-0.29), RIG: 25.29 (-0.56), KGC: 2.85 (-0.11), APT: 2.84 (+0.11), ANF: 28.81 (-0.13), MITK: 3.89 (-0.07), ZNGA: 2.68 (-0.03), CNET: 1.83 (-0.03), KING: 16.07 (-0.03), NETE: 1.35 (unch), SLXP: 104.96 (-0.43), RPRX: 9.07 (-0.12), NADL: 3.71 (-0.26), PGNX: 6.41 (-0.13), AVNR: 13.90 (+0.20), FSLR: 49.01 (-0.45), DVA: 74.97 (-0.26), NDLS: 22.55 (-0.10), ICPT: 157.87 (-4.63), AGIO: 91.55 (+7.74), PLNR: 7.23 (-0.16)
Agios Pharmaceuticals EPS of $0.10
Seeking Alpha - at Seeking Alpha - Fri Nov 07, 6:11AM CST
AGIO: 91.60 (+7.79)
Agios Pharmaceuticals posts 3Q profit
Automated Insights - Fri Nov 07, 6:09AM CST
CAMBRIDGE, Mass. (AP) _ Agios Pharmaceuticals Inc. (AGIO) on Friday reported earnings of $3.7 million, or 10 cents per share, in its third quarter.
AGIO: 91.60 (+7.79)
Agios Pharmaceuticals Reports Third Quarter 2014 Financial Results
GlobeNewswire - Fri Nov 07, 6:00AM CST
Agios Pharmaceuticals, Inc. (Nasdaq:AGIO), a leader in the fields of cancer metabolism and rare genetic disorders of metabolism, today reported business highlights and financial results for the third quarter ended September 30, 2014.
AGIO: 91.60 (+7.79)
Notable earnings before Friday’s open
Seeking Alpha - at Seeking Alpha - Thu Nov 06, 4:30PM CST
BAM: 49.66 (-0.22), ERF: 15.01 (-0.14), LXP: 10.96 (-0.01), PGEM: 12.29 (-0.14), CCOI: 34.99 (-0.16), TTI: 7.99 (-0.17), SJI: 56.40 (-0.15), NXST: 47.08 (-0.32), VSAT: 65.70 (+0.16), MT: 12.28 (-0.17), LXU: 33.33 (-0.40), HUM: 138.11 (-1.18), PGNX: 6.41 (-0.13), MHR: 4.55 (-0.07), CTB: 32.52 (unch), IDRA: 2.54 (+0.06), ISIS: 50.00 (+0.29), BPL: 81.59 (+0.19), SSP: 19.61 (-0.03), AGIO: 91.60 (+7.79), EBIX: 16.10 (-0.13)
Will Agios (AGIO) Disappoint in the Q3 Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 4:10PM CST
Agios (AGIO), which is scheduled to report third-quarter results on Nov 7, had delivered a negative earnings surprise of 14.89% in the last quarter.
MNK: 84.79 (-4.01), RNA: 11.45 (-0.05), AGIO: 91.72 (+7.91), CELG: 106.03 (-0.75)
Agios Pharmaceuticals to Present Clinical and Preclinical Data at the 2014 American Society of Hematology Annual Meeting
GlobeNewswire - Thu Nov 06, 8:46AM CST
New Data from Ongoing Phase 1 AG-221 Trial Accepted for Oral Presentation
AGIO: 91.72 (+7.91)
Critical Alerts For LinkedIn, Imperva Inc, Norfolk Southern, Halliburton and Agios Pharmaceuticals Released By InvestorsObserver
PR Newswire - Mon Nov 03, 8:31AM CST
InvestorsObserver issues critical PriceWatch Alerts for LNKD, IMPV, NSC, HAL and AGIO.
NSC: 114.63 (-0.75), LNKD: 217.10 (-3.97), HAL: 48.15 (-0.39), AGIO: 91.72 (+7.91), IMPV: 41.32 (-1.21)
Super Important Biotech and Drug Stock Events for November
at The Street - Mon Nov 03, 7:24AM CST
A cheat sheet of earnings, medical meetings, FDA approval decisions and clinical trial results for healthcare investors.
GILD: 101.71 (-2.00), CLVS: 50.90 (-2.88), ARWR: 5.95 (unch), ACHN: 13.11 (-0.20), MRK: 59.19 (-0.70), RTRX: 8.90 (-0.13), RGLS: 17.32 (-0.80), EPZM: 23.07 (-0.36), AGIO: 91.72 (+7.91), RMTI: 9.99 (-0.29), ARNA: 4.21 (-0.10), KERX: 15.48 (-0.06)
Cramer's Lightning Round - Isis Pharmaceuticals Has The Best Pipeline (10/28/14)
SA Editor Miriam Metzinger - Seeking Alpha - Wed Oct 29, 5:59AM CDT
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Tuesday October 2 8. Bullish Calls: Isis Pharmaceuticals (NASDAQ: ISIS ): "Isis got slammed, and (the selloff) was overdone. It has the best pipeline...
GS: 189.02 (-0.62), RICE: 25.65 (+0.15), ISIS: 50.00 (+0.29), CYBR: 42.09 (-0.58), GNC: 43.05 (+0.16), HAL: 48.15 (-0.39), AGIO: 91.72 (+7.91), FTNT: 26.55 (-0.40)
'Mad Money' Lightning Round: I'm Sticking With Isis Pharmaceuticals
at The Street - Wed Oct 29, 5:00AM CDT
Cramer says Halliburton is a buy, buy, buy and GNC needs to merge with Vitamin Shoppe.
VSI: 46.24 (-0.17), RICE: 25.65 (+0.15), GS: 189.02 (-0.62), FEYE: 31.30 (-0.57), ISIS: 50.00 (+0.29), CYBR: 42.09 (-0.58), GNC: 43.05 (+0.16), HAL: 48.15 (-0.39), EOG: 97.66 (-0.01), AGIO: 91.72 (+7.91), FTNT: 26.55 (-0.40)
Recent News posted below.
Agios Pharmaceuticals Inc AGIO other info.
http://investorshangout.com/Agios-Pharmaceuti...GIO-90049/
AGIO Agios Pharmaceuticals Inc Recent Headline News
Stock Futures Take A Data Dive; Tesla Falls On Outlook Change
at Investor's Business Daily - 1 hr 19 mins ago
Stock futures fell out of flat trade to moderate losses ahead of Wednesday's open after a mixed read on October homebuilding activity. Dow futures slumped 18.8 points below fair market value. Nasdaq 100 futures traded down 6.3 points. S&P 500 futures...
SPLS: 13.98 (+1.22), LEJU: 12.45 (-1.71), TSLA: 248.10 (-9.60), FCAU: 12.18 (-0.63), LITB: 7.75 (+0.11), TTM: 46.46 (-0.70), DL: 17.75 (+2.78), VA: 36.84 (-0.21), TGT: 71.07 (+3.56), GM: 32.10 (-0.17), AGIO: 91.55 (+7.74), LOW: 61.76 (+3.23), HMC: 31.03 (-0.62), EJ: 8.66 (-0.87), PETM: 76.40 (+2.78)
Agios leukemia drug candidate shows clinical activity in Phase 1 trial
Seeking Alpha - at Seeking Alpha - 1 hr 29 mins ago
AGIO: 91.55 (+7.74)
Agios Cancer 'Metabolism' Drug Clears Bone Marrow of Leukemic Cells
at The Street - Tue Nov 18, 5:02PM CST
The experimental drug from Agios, designed to attack the "metabolism" of cancer cells, has demonstrated early but strong clinical responses in a study involving patients with advanced leukemia.
AGIO: 91.55 (+7.74), CELG: 106.02 (-0.76)
Agios Pharmaceuticals Announces Early Phase 1 Data Showing Clinical Activity of AG-120 as a Single Agent in Advanced Acute Myeloid Leukemia (AML)
GlobeNewswire - Tue Nov 18, 5:01PM CST
-Significant Clinical Responses and Reduction of 2HG Biomarker Provide Early Validation of Mutant IDH1 as a Therapeutic Target in AML -
AGIO: 91.55 (+7.74)
Jim Cramer Says to Buy Six Flags, Avoid SeaWorld Entertainment
at The Street - Wed Nov 12, 1:20PM CST
TheStreet's Jim Cramer says investors shouldn't be tricked by SeaWorld's attractive dividend yield. Instead, stick with Six Flags Entertainment.
SEAS: 17.20 (+0.14), SIX: 40.53 (-0.27), AGIO: 91.55 (+7.74)
Nasdaq stocks posting largest percentage increases
AP - Tue Nov 11, 5:02PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
ICUI: 84.37 (-1.19), OREX: 5.54 (-0.08), PCMI: 8.86 (+0.07), CYAN: 7.69 (-0.15), ACHN: 13.10 (-0.21), TGTX: 14.49 (-0.28), AGIO: 91.70 (+7.89), LIOX: 5.05 (-0.09), SAJA: 5.97 (-0.14), PLNR: 7.23 (-0.16)
Biotech Weekly: When Mid Caps Are Priced Nearly For Perfection
Daniel Ward - at Seeking Alpha - Mon Nov 10, 9:28AM CST
XBI: 170.72 (-0.66), SLXP: 104.96 (-0.43), ICPT: 157.87 (-4.63), IBB: 293.56 (-1.69), AGIO: 91.70 (+7.89)
Agios Pharmaceuticals' (AGIO) CEO David Schenkein on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Sat Nov 08, 6:31AM CST
AGIO: 91.70 (+7.89)
Premarket Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Nov 07, 8:14AM CST
BEBE: 2.63 (+0.06), ANET: 76.88 (+0.08), TKMR: 16.11 (-0.26), ORBC: 6.21 (-0.13), MDRX: 12.05 (-0.15), RMTI: 9.99 (-0.29), CTIC: 2.22 (-0.06), SHLD: 35.65 (-0.26), UBNT: 29.30 (-0.29), RIG: 25.29 (-0.56), KGC: 2.85 (-0.11), APT: 2.84 (+0.11), ANF: 28.81 (-0.13), MITK: 3.89 (-0.07), ZNGA: 2.68 (-0.03), CNET: 1.83 (-0.03), KING: 16.07 (-0.03), NETE: 1.35 (unch), SLXP: 104.96 (-0.43), RPRX: 9.07 (-0.12), NADL: 3.71 (-0.26), PGNX: 6.41 (-0.13), AVNR: 13.90 (+0.20), FSLR: 49.01 (-0.45), DVA: 74.97 (-0.26), NDLS: 22.55 (-0.10), ICPT: 157.87 (-4.63), AGIO: 91.55 (+7.74), PLNR: 7.23 (-0.16)
Agios Pharmaceuticals EPS of $0.10
Seeking Alpha - at Seeking Alpha - Fri Nov 07, 6:11AM CST
AGIO: 91.60 (+7.79)
Agios Pharmaceuticals posts 3Q profit
Automated Insights - Fri Nov 07, 6:09AM CST
CAMBRIDGE, Mass. (AP) _ Agios Pharmaceuticals Inc. (AGIO) on Friday reported earnings of $3.7 million, or 10 cents per share, in its third quarter.
AGIO: 91.60 (+7.79)
Agios Pharmaceuticals Reports Third Quarter 2014 Financial Results
GlobeNewswire - Fri Nov 07, 6:00AM CST
Agios Pharmaceuticals, Inc. (Nasdaq:AGIO), a leader in the fields of cancer metabolism and rare genetic disorders of metabolism, today reported business highlights and financial results for the third quarter ended September 30, 2014.
AGIO: 91.60 (+7.79)
Notable earnings before Friday’s open
Seeking Alpha - at Seeking Alpha - Thu Nov 06, 4:30PM CST
BAM: 49.66 (-0.22), ERF: 15.01 (-0.14), LXP: 10.96 (-0.01), PGEM: 12.29 (-0.14), CCOI: 34.99 (-0.16), TTI: 7.99 (-0.17), SJI: 56.40 (-0.15), NXST: 47.08 (-0.32), VSAT: 65.70 (+0.16), MT: 12.28 (-0.17), LXU: 33.33 (-0.40), HUM: 138.11 (-1.18), PGNX: 6.41 (-0.13), MHR: 4.55 (-0.07), CTB: 32.52 (unch), IDRA: 2.54 (+0.06), ISIS: 50.00 (+0.29), BPL: 81.59 (+0.19), SSP: 19.61 (-0.03), AGIO: 91.60 (+7.79), EBIX: 16.10 (-0.13)
Will Agios (AGIO) Disappoint in the Q3 Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 4:10PM CST
Agios (AGIO), which is scheduled to report third-quarter results on Nov 7, had delivered a negative earnings surprise of 14.89% in the last quarter.
MNK: 84.79 (-4.01), RNA: 11.45 (-0.05), AGIO: 91.72 (+7.91), CELG: 106.03 (-0.75)
Agios Pharmaceuticals to Present Clinical and Preclinical Data at the 2014 American Society of Hematology Annual Meeting
GlobeNewswire - Thu Nov 06, 8:46AM CST
New Data from Ongoing Phase 1 AG-221 Trial Accepted for Oral Presentation
AGIO: 91.72 (+7.91)
Critical Alerts For LinkedIn, Imperva Inc, Norfolk Southern, Halliburton and Agios Pharmaceuticals Released By InvestorsObserver
PR Newswire - Mon Nov 03, 8:31AM CST
InvestorsObserver issues critical PriceWatch Alerts for LNKD, IMPV, NSC, HAL and AGIO.
NSC: 114.63 (-0.75), LNKD: 217.10 (-3.97), HAL: 48.15 (-0.39), AGIO: 91.72 (+7.91), IMPV: 41.32 (-1.21)
Super Important Biotech and Drug Stock Events for November
at The Street - Mon Nov 03, 7:24AM CST
A cheat sheet of earnings, medical meetings, FDA approval decisions and clinical trial results for healthcare investors.
GILD: 101.71 (-2.00), CLVS: 50.90 (-2.88), ARWR: 5.95 (unch), ACHN: 13.11 (-0.20), MRK: 59.19 (-0.70), RTRX: 8.90 (-0.13), RGLS: 17.32 (-0.80), EPZM: 23.07 (-0.36), AGIO: 91.72 (+7.91), RMTI: 9.99 (-0.29), ARNA: 4.21 (-0.10), KERX: 15.48 (-0.06)
Cramer's Lightning Round - Isis Pharmaceuticals Has The Best Pipeline (10/28/14)
SA Editor Miriam Metzinger - Seeking Alpha - Wed Oct 29, 5:59AM CDT
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Tuesday October 2 8. Bullish Calls: Isis Pharmaceuticals (NASDAQ: ISIS ): "Isis got slammed, and (the selloff) was overdone. It has the best pipeline...
GS: 189.02 (-0.62), RICE: 25.65 (+0.15), ISIS: 50.00 (+0.29), CYBR: 42.09 (-0.58), GNC: 43.05 (+0.16), HAL: 48.15 (-0.39), AGIO: 91.72 (+7.91), FTNT: 26.55 (-0.40)
'Mad Money' Lightning Round: I'm Sticking With Isis Pharmaceuticals
at The Street - Wed Oct 29, 5:00AM CDT
Cramer says Halliburton is a buy, buy, buy and GNC needs to merge with Vitamin Shoppe.
VSI: 46.24 (-0.17), RICE: 25.65 (+0.15), GS: 189.02 (-0.62), FEYE: 31.30 (-0.57), ISIS: 50.00 (+0.29), CYBR: 42.09 (-0.58), GNC: 43.05 (+0.16), HAL: 48.15 (-0.39), EOG: 97.66 (-0.01), AGIO: 91.72 (+7.91), FTNT: 26.55 (-0.40)
(0)
(0)Agios Pharmaceuticals Inc. (AGIO) Stock Research Links
Scroll down for more posts ▼